TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35366823

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) interventions
Number of subjects: 38
Study: 33713680

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 712

Group type: COMPARATOR
Intervention: Laser
Number of subjects: 712

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 712
Study: 35078830

Group type: EXPERIMENTAL
Intervention: PCT-guided algorithm used in conjunction with best practice
Number of subjects: 1942

Group type: COMPARATOR
Intervention: Best practice alone
Number of subjects: 1942
Study: 34544468

Group type: EXPERIMENTAL
Intervention: Dose Painting (DP) procedure with doses of 80, 85, and 91 Gy delivered to PTV1, PTV2, and PTV3 respectively.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional IMRT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Three-Dimensional Conformal Radiation Therapy (3DCRT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Post-treatment follow-up after 4 months
Number of subjects: 20
Study: 35213077

Group type: EXPERIMENTAL
Intervention: Nx4
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33573608

Group type: EXPERIMENTAL
Intervention: Inpatient energy management education (IEME) + high-intensity interval training (HIIT)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR) + moderate continuous training (MCT)
Number of subjects: 106
Study: 34008258

Group type: EXPERIMENTAL
Intervention: Increased communication and sharing of resources between academic centers and community hospitals
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Community hospital engagement
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Initiation of the project in the community hospitals
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Recruiting patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Community hospitals' willingness to participate in RCTs
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lack of capacity for research in community hospitals
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Trial coordinating sites' efforts
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Invisibility of community hospitals to research investigators
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lack of research infrastructure in community hospitals
Number of subjects: 18
Study: 33551116

Group type: EXPERIMENTAL
Intervention: 3D instructional video
Number of subjects: 108

Group type: COMPARATOR
Intervention: 2D instructional video
Number of subjects: 108
Study: 33471654

Group type: EXPERIMENTAL
Intervention: 200,000 IU intramuscular D2
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 400,000 IU intramuscular D2
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 600,000 IU intramuscular D2
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 40
Study: 35134995

Group type: EXPERIMENTAL
Intervention: VRC07-523LS 20 mg/kg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PGT121 10 mg/kg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PGT121 20 mg/kg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both antibodies
Number of subjects: 45

Group type: COMPARATOR
Intervention: VRC07-523LS and PGT121
Number of subjects: 45
Study: 35474643

Group type: EXPERIMENTAL
Intervention: Pharmacist-based coaching (12 weekly face-to-face sessions)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no coaching)
Number of subjects: 240
Study: 35508351

Group type: EXPERIMENTAL
Intervention: Fibrinogen replacement using fibrinogen concentrate (FC)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cryoprecipitate
Number of subjects: 68
Study: 33908180

Group type: EXPERIMENTAL
Intervention: Machine Learning Algorithm (MLA)
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Logistic Regression Model (LRM)
Number of subjects: 553

Group type: COMPARATOR
Intervention: AST-to-Platelet ratio
Number of subjects: 553

Group type: COMPARATOR
Intervention: FIB-4 score
Number of subjects: 553

Group type: COMPARATOR
Intervention: NAFLD Fibrosis Score
Number of subjects: 553
Study: 33150799

Group type: EXPERIMENTAL
Intervention: Selpercatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carboplatin or cisplatin and pemetrexed chemotherapy with or without pembrolizumab
Number of subjects: 0
Study: 33998672

Group type: EXPERIMENTAL
Intervention: BIA 10‐2474 (0.25–100 mg single dose)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: BIA 10‐2474 (2.5–50 mg repeated oral doses for 10 days)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: BIA 10‐2474 (50 mg repeated administration)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: BIA 10‐2474
Number of subjects: 116
Study: 33740232

Group type: EXPERIMENTAL
Intervention: Epilepsy surgery (resective surgeries such as lesionectomy, lobectomy, multilobar resections; disconnective surgeries such as corpus callosotomy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-surgical screening workup including high-resolution epilepsy protocol brain MRI and high-quality in-patient video EEG evaluation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advanced investigations (PET, SPECT, MEG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional MRI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Invasive long-term EEG monitoring (using stereotactically implanted intracranial depth electrodes or subdural grids)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neuromodulation (DBS, VNS, RNS)
Number of subjects: 0
Study: 32069361

Group type: EXPERIMENTAL
Intervention: 810-nm diode laser
Number of subjects: 20
Study: 35873352

Group type: EXPERIMENTAL
Intervention: Autologous Platelet-Rich Plasma (aPRP) combined with rabeprazole
Number of subjects: 27

Group type: COMPARATOR
Intervention: Rabeprazole only (Control)
Number of subjects: 27
Study: 32377957

Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg)
Number of subjects: 76
Study: 35700617

Group type: EXPERIMENTAL
Intervention: Kinesiotaping in addition to standard treatment (oral analgesics: acetaminophen q6h 1000 mg and NSAID, and sling if shoulder injury)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard treatment (oral analgesics: acetaminophen q6h 1000 mg and NSAID, and sling if shoulder injury)
Number of subjects: 83
Study: 32918917

Group type: EXPERIMENTAL
Intervention: Nonlinear regression analysis for predicting tissue/blood distribution coefficients
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Individual tissue/blood distribution coefficient models
Number of subjects: 282
Study: 36493331

Group type: EXPERIMENTAL
Intervention: Mepitel film (MF)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 376
Study: 34620193

Group type: EXPERIMENTAL
Intervention: Personalized music intervention
Number of subjects: 54
Study: 32966293

Group type: EXPERIMENTAL
Intervention: NVP plus 3TC (lamivudine)
Number of subjects: 20
Study: 35490691

Group type: EXPERIMENTAL
Intervention: Algorithm-centred care
Number of subjects: 1748

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1748
Study: 34933684

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (0-14 days regimen)
Number of subjects: 809

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (0-21 days regimen)
Number of subjects: 809

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (0-28 days regimen)
Number of subjects: 809
Study: 36044097

Group type: EXPERIMENTAL
Intervention: Light therapy (warm white-light exposure at 10,000 lx for 30 min per day for 12 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 13
Study: 34580169

Group type: EXPERIMENTAL
Intervention: Impedance cardiography (ICG) guided treatment strategy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 102
Study: 33429088

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 120
Study: 32123573

Group type: EXPERIMENTAL
Intervention: Jet injector lidocaine delivery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional needle lidocaine delivery
Number of subjects: 0
Study: 33594596

Group type: EXPERIMENTAL
Intervention: Double-lumen endotracheal tubes (DL-ETT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bronchial blockers (BB)
Number of subjects: 39
Study: 32367144

Group type: EXPERIMENTAL
Intervention: tACS at 10 Hz
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition (no tACS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: tACS at 70 Hz
Number of subjects: 30
Study: 35022623

Group type: COMPARATOR
Intervention: Portable immunosensor for detecting Mycobacterium tuberculosis (MTB) in sputum; optimal source voltage (0.3 V) and gate voltage (0.1 V) used.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Portable immunosensor for detecting Mycobacterium tuberculosis (MTB) in sputum; anti-interference tests with common proteins in simulated saliva.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Portable immunosensor for detecting Mycobacterium tuberculosis (MTB) in sputum; optimized dilution gradient of actual TB sputum samples.
Number of subjects: 0
Study: 32409986

Group type: EXPERIMENTAL
Intervention: Mothers and Babies Course (intervention group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study: 32016788

Group type: EXPERIMENTAL
Intervention: IVT‐AFL T&E with 2-week adjustments
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: IVT‐AFL T&E with 4-week adjustments
Number of subjects: 246
Study: 36192724

Group type: EXPERIMENTAL
Intervention: selfBACK app
Number of subjects: 26
Study: 33605206

Group type: EXPERIMENTAL
Intervention: Kidney discard risk index (derived from 21 factors)
Number of subjects: 102246

Group type: EXPERIMENTAL
Intervention: Bottom 10th percentile of kidney discard risk index
Number of subjects: 102246

Group type: EXPERIMENTAL
Intervention: Top 10th percentile of kidney discard risk index
Number of subjects: 102246

Group type: EXPERIMENTAL
Intervention: Predictive factors for discard
Number of subjects: 102246
Study: 35969882

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) alone
Number of subjects: 10739

Group type: COMPARATOR
Intervention: Estrogen-alone therapy (from meta-analysis)
Number of subjects: 10739
Study: 34105307

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35435791

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Therapy (MBT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 51
Study: 33465316

Group type: EXPERIMENTAL
Intervention: Discontinuing hypertonic saline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discontinuing dornase alfa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuing hypertonic saline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuing dornase alfa
Number of subjects: 0
Study: 32086889

Group type: EXPERIMENTAL
Intervention: Step-down pharmacotherapy (n=67)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Maintaining therapy (n=68)
Number of subjects: 135
Study: 34744069

Group type: EXPERIMENTAL
Intervention: Sling Suspension Therapy (SST)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gym Ball Exercises (GBE)
Number of subjects: 40
Study: 33258518

Group type: EXPERIMENTAL
Intervention: Neurology ultrasound workshop (n = 57)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Traditional curriculum control group
Number of subjects: 360
Study: 34920046

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 42010

Group type: EXPERIMENTAL
Intervention: High-dose TXA (≥50 mg/kg)
Number of subjects: 42010
Study: 34772753

Group type: EXPERIMENTAL
Intervention: Oral fixation device
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional fixation
Number of subjects: 120
Study: 36409542

Group type: EXPERIMENTAL
Intervention: 9-day self-guided body image and self-compassion mHealth app (n=149)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Active waitlist control group (n=161)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Both apps (mHealth app and active waitlist control)
Number of subjects: 310
Study: 33176306

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric care (CGC) delivered by a geriatrician, physiotherapist, and occupational therapist.
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 53
Study: 34599603

Group type: EXPERIMENTAL
Intervention: Extended early intervention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 220
Study: 33631007

Group type: EXPERIMENTAL
Intervention: Sweet flavored NVPs
Number of subjects: 886

Group type: COMPARATOR
Intervention: Tobacco flavored NVPs
Number of subjects: 886

Group type: COMPARATOR
Intervention: Menthol flavored NVPs
Number of subjects: 886

Group type: EXPERIMENTAL
Intervention: Vapers who quit smoking in 2018
Number of subjects: 886

Group type: COMPARATOR
Intervention: Continuing smokers in 2018
Number of subjects: 886
Study: 32902321

Group type: EXPERIMENTAL
Intervention: Intravenous IgG (IVIG) treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Untreated group (Control)
Number of subjects: 80
Study: 33737614

Group type: COMPARATOR
Intervention: 350 g/kg iso-lipid test diet
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 400 g/kg iso-lipid test diet
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 450 g/kg iso-lipid test diet
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 550 g/kg iso-lipid test diet
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 500 g/kg iso-lipid test diet
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Optimum protein level
Number of subjects: 450
Study: 32620339

Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP) 3 g/d for 28 days
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 34513873

Group type: EXPERIMENTAL
Intervention: Polyglactin 10-0 sutures
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nylon 10-0 sutures
Number of subjects: 80
Study: 32247559

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 units/day)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg/day)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Vitamin E + C
Number of subjects: 81

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 81
Study: 35321588

Group type: EXPERIMENTAL
Intervention: Radial shortening
Number of subjects: 52

Group type: COMPARATOR
Intervention: Capitate shortening
Number of subjects: 52
Study: 33523031

Group type: EXPERIMENTAL
Intervention: Sensorineural hearing loss group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (normative values according to the scale)
Number of subjects: 200
Study: 34709684

Group type: EXPERIMENTAL
Intervention: THN102 200/2 (200 mg/d modafinil with 2 mg/d flecainide)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: THN102 200/18 (200 mg/d modafinil with 18 mg/d flecainide)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 32990504

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (laser therapy over acupuncture points, λ=786.94 nm, 20 sec per point, fluency=33.5 Jcm2, energy=1 J, number of points=12)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Occlusal splint (OS) therapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sham laser therapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group without SB
Number of subjects: 76
Study: 32881842

Group type: COMPARATOR
Intervention: Informed of the load (control group, n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Noninformed (blinded group, n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (60% and 80% 1RM protocols)
Number of subjects: 20
Study: 35888678

Group type: EXPERIMENTAL
Intervention: Online learning (Group O)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hands-on learning (Group H)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 33190513

Group type: EXPERIMENTAL
Intervention: Fast Foes condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fast Friends condition
Number of subjects: 0
Study: 35106970

Group type: EXPERIMENTAL
Intervention: School-linked text message intervention
Number of subjects: 26
Study: 33401161

Group type: EXPERIMENTAL
Intervention: Playing conventional board games with traditional number dice (dot faces numbered from one to six)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Playing board games with color or non-numerical symbol dice
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Follow-up test 1 year after the intervention
Number of subjects: 30
Study: 33693315

Group type: EXPERIMENTAL
Intervention: Postpregnancy family planning interventions focusing on quality FP counseling and service provision prior to discharge.
Number of subjects: 8796

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 8796

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 8796
Study: 34753522

Group type: EXPERIMENTAL
Intervention: Peer Support intervention (PSG)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Minimal Support intervention (MSG)
Number of subjects: 31
Study: 33704056

Group type: EXPERIMENTAL
Intervention: Serum endocan levels in RHD group
Number of subjects: 29

Group type: COMPARATOR
Intervention: Serum endocan levels in control group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Urinary endocan levels in RHD group
Number of subjects: 29

Group type: COMPARATOR
Intervention: Urinary endocan levels in control group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Correlation of serum endocan level with uric acid level in RHD group
Number of subjects: 29
Study: 34191081

Group type: EXPERIMENTAL
Intervention: 4 mg perampanel
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 8 mg perampanel
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 33773395

Group type: EXPERIMENTAL
Intervention: Passive body frame with idealized models
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Passive body frame
Number of subjects: 568

Group type: COMPARATOR
Intervention: Active body frame
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Non-idealized models
Number of subjects: 568
Study: 32444220

Group type: EXPERIMENTAL
Intervention: Autologous umbilical cord blood infusion
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Allogeneic umbilical cord blood infusion
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 35579006

Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33°C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fever control alone
Number of subjects: 0
Study: 34287251

Group type: EXPERIMENTAL
Intervention: Scalp cooling application
Number of subjects: 74

Group type: COMPARATOR
Intervention: Traditional chemotherapy setting
Number of subjects: 74

Group type: COMPARATOR
Intervention: No scalp cooling application
Number of subjects: 74
Study: 35853600

Group type: EXPERIMENTAL
Intervention: Performance feedback intervention (introductory training module, weekly electronic 'Quick Tips', and 3 individualized performance feedback reports)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no performance feedback)
Number of subjects: 48
Study: 33605397

Group type: EXPERIMENTAL
Intervention: 50% Nitrous oxide (N2O) administered for 60 minutes twice a week for 4 weeks.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (100% oxygen) administered for 60 minutes twice a week for 4 weeks.
Number of subjects: 23
Study: 35230058

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) - 5 consecutive daily 90-minute sessions at 2.0 atmospheres absolute with 100% oxygen
Number of subjects: 31

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 31
Study: 32167863

Group type: EXPERIMENTAL
Intervention: Lenvatinib 20 mg once daily plus Pembrolizumab 200 mg intravenously once every 3 weeks
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Lenvatinib plus Pembrolizumab
Number of subjects: 108
Study: 33179515

Group type: EXPERIMENTAL
Intervention: Oral combined estradiol (E2) and progesterone therapy
Number of subjects: 1173
Study: 32005747

Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine
Number of subjects: 111
Study: 34713713

Group type: EXPERIMENTAL
Intervention: Red meat diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: White meat diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-meat diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fecal culture measuring choline- and carnitine-trimethylamine lyase activity
Number of subjects: 0
Study: 33162830

Group type: EXPERIMENTAL
Intervention: Cytokine biomarkers (CCL27, IFN‐γ, IL‐4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokine biomarkers (serum)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokine biomarkers (CSF)
Number of subjects: 0
Study: 35277071

Group type: EXPERIMENTAL
Intervention: High dose iron and curcumin (FS65_Curc)
Number of subjects: 155

Group type: COMPARATOR
Intervention: High dose iron and curcumin placebo (FS65_Plac)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Low dose iron and curcumin (FS18_Curc)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Low dose iron and curcumin placebo (FS18_Plac)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Iron and curcumin placebo (FS0_Plac)
Number of subjects: 155
Study: 33864725

Group type: EXPERIMENTAL
Intervention: Oral allopurinol 300 mg twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35141805

Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound stimulation (TUS) combined with conventional cognitive rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cognitive rehabilitation training and sham-TUS stimulation
Number of subjects: 60